HomeCompareESRX vs DIVO

ESRX vs DIVO: Dividend Comparison 2026

ESRX yields 2.17% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $8.1K in total portfolio value
10 years
ESRX
ESRX
● Live price
2.17%
Share price
$92.33
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.9K
Annual income
$249.17
Full ESRX calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — ESRX vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESRXDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESRX + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESRX pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESRX
Annual income on $10K today (after 15% tax)
$184.12/yr
After 10yr DRIP, annual income (after tax)
$211.79/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, DIVO beats the other by $645.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESRX + DIVO for your $10,000?

ESRX: 50%DIVO: 50%
100% DIVO50/50100% ESRX
Portfolio after 10yr
$26.9K
Annual income
$628.82/yr
Blended yield
2.34%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESRX buys
0
DIVO buys
0
No recent congressional trades found for ESRX or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESRXDIVO
Forward yield2.17%6.62%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$22.9K$31.0K
Annual income after 10y$249.17$1,008.47
Total dividends collected$2.3K$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ESRX vs DIVO ($10,000, DRIP)

YearESRX PortfolioESRX Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$10,917$216.61$11,362$661.96$445.00DIVO
2$11,902$221.00$12,860$702.91$958.00DIVO
3$12,960$225.18$14,504$743.56$1.5KDIVO
4$14,096$229.16$16,303$783.73$2.2KDIVO
5$15,316$232.95$18,268$823.31$3.0KDIVO
6$16,625$236.55$20,408$862.17$3.8KDIVO
7$18,029$239.96$22,737$900.20$4.7KDIVO
8$19,534$243.20$25,266$937.31$5.7KDIVO
9$21,147$246.26$28,008$973.42$6.9KDIVO
10$22,877$249.17$30,977$1,008.47$8.1KDIVO

ESRX vs DIVO: Complete Analysis 2026

ESRXStock

Express Scripts is a pharmacy benefit management (PBM) organization founded in 1986. It offers integrated services like pharmacy claims processing, home delivery, formulary management, specialty pharmacy via Accredo, and data-driven drug utilization insights. The company is a subsidiary of Cigna following a $54 billion acquisition completed in December 2018.

Full ESRX Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this ESRX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESRX vs SCHDESRX vs JEPIESRX vs OESRX vs KOESRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.